Product Description
Source LDPath is the largest and most technically advanced private provider of cellular and digital pathology services in the UK.
Providing in-house digital pathology, Source LDPath can provide NHS Trusts and private hospital providers with a complete digital pathology solution, including the installation of on-site scanning facilities.
With a focus on digital pathology and AI, Source LDPath provides a streamlined customer experience and improved diagnostic pathways for private healthcare, NHS, smaller clinics, leading to faster diagnosis and helping clear backlog of elective surgeries.
Source LDPath is the largest and most technically advanced private provider of cellular and digital pathology services in the UK.
Providing in-house digital pathology, Source LDPath can provide NHS Trusts and private hospital providers with a complete digital pathology solution, including the installation of on-site scanning facilities.
Benefits of our Service…
- 200+ Consultant Pathologists
- Largest UK Digital Capacity Including Archiving
- Rapid Turnaround Times
- Largest Second Opinion Network
- Integrated LIMS Solution
Your partner of choice because…
- All specialisms reported
- Cut up and processing of wet samples
- Short and long term service solutions
- Digital Pathology platform placement
- NPEX digital exchange
- NHS Framework
- MDT provision
Digital reporting with AI technology
LDPath is engaged with approximately 80 specialist consultant pathologists with approximately 75% of results reported digitally.
Source LDPath offers digital reporting with innovative AI technology. Artificial intelligence (AI) applies deep machine learning technology to generate powerful computer algorithms that assist pathologists in making diagnoses.
Combining digital reporting with innovative AI technology enhances the diagnostic service, by:
-
- Improving diagnostic accuracy
- Easing pathologist workload
- Accelerating pathology reporting TAT
- Reducing patient waiting times
.
Digital reporting with AI technology
LDPath is engaged with approximately 80 specialist consultant pathologists with approximately 75% of results reported digitally.
Source LDPath offers digital reporting with innovative AI technology. Artificial intelligence (AI) applies deep machine learning technology to generate powerful computer algorithms that assist pathologists in making diagnoses.
Combining digital reporting with innovative AI technology enhances the diagnostic service, by:
-
- Improving diagnostic accuracy
- Easing pathologist workload
- Accelerating pathology reporting TAT
- Reducing patient waiting times
Diagnostic Services
Source LDPath produces cutting-edge companion diagnostic predictive and prognostic testing for cancer and other diseases. Our unparalleled combination of expertise in histopathology, coupled with the latest molecular diagnostics, enables us to provide a unique service to support specialist diagnostics.
- Mutation Status Testing (e.g: KRAS/EGFR/BRAF)
- NGS gene panel targeted sequencing
- Personalised Medicine testing (e.g ToxNav)
- Hormone Receptor Testing
- Routine and Specialist Immunohistochemistry Assays (IHC)
- In-situ hybridisation (ISH)
- Circulating Tumour cell assessment (CTC)
